Drug Profile
Helicobacter pylori vaccine - Emergent BioDefense Operations Lansing
Alternative Names: HelivaxLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Emergent BioDefense Operations Lansing
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Helicobacter infections
Most Recent Events
- 09 Feb 2007 Discontinued - Phase-I for Helicobacter infections in USA (PO)
- 16 Jun 2003 The assets of Antex Biologics and Antex Pharma have been acquired by BioPort Corporation
- 31 Jan 2003 Antex Biologics has received approval from the FDA for its IND application for its Helicobacter pylori vaccine